HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.
Vincenzo MalagninoCarlotta CervaAntonella CingolaniFrancesca Ceccherini-SilbersteinAlessandra VergoriGianluca CuomoCarlo Federico PernoMassimo PuotiAntonella d'Arminio MonforteAlessandro Cozzi-LepriMassimo AndreoniLoredana Sarmatinull nullPublished in: Open forum infectious diseases (2020)
HBcAb+ contributes to liver damage in HIV+/HCV+/HBcAb+/HBsAg- subjects. A careful monitoring for signs of previous HBV infection is needed in this kind of patients.
Keyphrases
- antiretroviral therapy
- hepatitis c virus
- hiv infected patients
- human immunodeficiency virus
- hiv infected
- hiv positive
- hepatitis b virus
- hiv aids
- end stage renal disease
- hiv testing
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- men who have sex with men
- peritoneal dialysis
- early onset
- oxidative stress
- drug induced
- liver failure